It's not clear how a willingness for the end-users to pay $3-5 monthly would help the situation given that he can't use $$ to increase his quota-controlled access to the api.
537 karma · joined February 26, 2009
The VMWare solution sounds like a simpler, pragmatic "hack" to solve the problem. It would be interesting to hear from someone that has used both technologies to see how they compare in practice.
On the question of fairness: Is it fair for people to die because they can't afford a life-saving drug? I'm sure that's what it boiled down to for the Indian government.
According to my math if Bayer priced the drug over here the same way they did in India relative to average per-capita income the drug would cost around $1.5 million per year. Would that change your perspective?
Unless there are other requirements I don't see why you'd suggest sorting the elements.